Jahrgang 2014
Hamm CW, Möllmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Mohr FW for the GARY-Executive Board (2014)
The German Aortic Valve Registry (GARY): in-hospital outcome.
Eur Heart J 35: 1588-1598Krum H, Schlaich MP, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD (2014)
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.
Lancet 383: 622-629Clever YP, Cremers B, von Scheidt W, Böhm M, Speck U, Scheller B (2014)
Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis.
Clin Res Cardiol 103: 21-27Pöss J, Mahfoud F, Ukena C, Esler MD, Schlaich M, Hering D, Cremers B, Laufs U, Böhm M (2014)
Association of vitamin D status and blood pressure response after renal denervation.
Clin Res Cardiol 103: 41-47Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Koon T, Yusuf S, Böhm M (2014)
Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND
Clin Res Cardiol 103: 149-159Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider G, Buecker A, SChneeweis C, Doltra A, Schlaich MP, Esler MD, Fleck E, Böhm M (2014)
Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.
Eur Heart J 35: 2224-2231Foulquier S, Böhm M, Schmieder R, Sleight P, Koon T, Yusuf S, Schumacher H, Unger T (2014)
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: aTelmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis.
J Hypertens 32: 1334-1341Schirmer SH, Sayed MM, Reil JC, Ukena C, Linz D, Kindermann M, Laufs U, Mahfoud F, Böhm M (2014)
Improvements of left-ventricular hypertrophy and diastolic function following renal denervation – Effects beyond blood pressure and heart rate reduction.
J Am Coll Cardiol 63: 1916-1923Kratz MT, Schumacher H, Sliwa K, Schmieder R, Pöss J, Mahfoud F, Unger T, Lonn E, Koon T, Mancia G, Sleight P, Yusuf S, Böhm M (2014)
Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients.
Eur J Prev Cardiol 21: 272-280Ewen S, Mahfoud F, Linz D, Pöss J, Cremers B, Kindermann I, Laufs U, Ukena C, Böhm M (2014)
Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension.
Hypertension 63: 839-845Voors AA, van Veldhuisen DJ, Robertson M, Ford I, Borer JS, Böhm M, Komajda M, Swedberg K, Tavazzi L on behalf of the SHIFT investigators (2014)
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
Eur J Heart Fail 16: 426-434Tebbe U, Tschöpe C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Strunz AM, Lins K, Böhm M (2014)
Registry in germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF.
Clin Res Cardiol 103: 665-673Böhm M, Pogue J, Kindermann I, Pöss J, Koon T, Yusuf S (2014)
Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
Eur J Heart Fail 16: 325-333Borer JS, Böhm M, Ford I, Robertson M, Komajda M, Tavazzi L, Swedberg K on behalf of the SHIFT investigators (2014)
Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).
Am J Cardiol 113: 497-503Perez-Moreno AC, Jhund PS, Macdonald MR, Petrie MC, Cleland JGF, Böhm M, van Veldhuisen DJ, Gullestad L, Wikstrand J, Kjekshus K, Lewsey JD, McMurray JJV (2014)
Fatigue as a predictor of outcome in patients with heart failure.
J Am Coll Cardiol HF 2: 187-197Liman TG, Bachelier-Walenta K, Neeb L, Rosinski J, Reuter U, Böhm M, Endres M (2014)
Circulating endothelial microparticles in female migraineurs with aura.
Cephalagia 35: 88-94Rogers JK, Jhund PS, Perez AC, Böhm M, Cleland JG, Gullestad L, Kjekshus J, van Veldhuisen DJ, Wikstrand J, Wedel H, McMurray JJV, PockockSJ (2014)
Effect of rosuvastatin on repeat heart failure hospitalizations.
J Am Coll Cardiol HF 2: 289-297Böhm M, Perez AC, Jhund PS, Reil JC, Komajda M, Zile MR, McKelvie RS, Anand IS, Massie BM, Carson PE, McMurray JJV on behalf of the I-Preserve Committees and Investigators (2014)
Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
Eur J Heart Fail 16: 778-787Lavall D, Selzer C, Schuster P, Lenski M, Adam O, Schäfers HJ, Böhm M, Laufs U (2014)
The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
J Biol Chem 289: 6656-6668Linz D, Hohl M, Schütze J, Mahfoud F, Speer T, Linz B, Hübschle T, Juretschke HP, Dechend R, Geisel J, Rütten H, Böhm M (2014)
Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation.
Am J Hypertens 28: 256-265Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP (2014)
Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
Eur Heart J 35: 1752-1759Tebbe, U, Tschöpe C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Strunz AM, Lins K, Böhm M (2014)
Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF
Clin Res Cardiol 103: 665-673Ukena C, Kindermann M, Mahfoud F, Geisel J, Lepper PM, Kandolf R, Böhm M, Kindermann I (2014)
Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis.
Clin Res Cardiol 103: 743-751Tzafriri AR, Mahfoud F, Keating JH, Markham PM, Spognardi A, Wong G, Fuimaono K, Böhm M, Edelman ER (2014)
Innervation patterns may limit response to endovascular renal denervation.
J Am Coll Cardiol 64: 1079-1087Del Rosario Espinoza Mora M, Böhm M, Link A (2014)
The Th17/Treg imbalance in patients with cardiogenic shock.
Clin Res Cardiol 103: 301-313Hoffmann MM, Werner C, Böhm M, Laufs U, Winkler K (2014)
Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease.
Cardiovasc Diabetol 13: 155Werner C, Filmer A, Fritsch M, Groenwald S, Gräber S, Böhm M, Laufs U (2014)
Risk prediction with triglycerides in patients with stable coronary disease on statin treatment.
Clin Res Cardiol 103: 984-997Lauten A, Figulla HR, Möllmann H, Holzhey D, Kötting J, Beckmann A, Veit C, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr FW, Hamm CW on behalf of the GARY Executive Board (2014)
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)
Euro Intervention 10: 850-859Cremers B, Link A, Werner C, Gorhan H, Simundic I, Matheis G, Scheller B, Böhm M (2014)
Pulsatile venoarterial perfusion using a novel synchronized cardiac assist device augments coronary artery blood flow during ventricular fibrillation.
Artificial Organs 39: 77-82Fuernau G, Pöss J, Denks D, Desch S, Heine GH, Eitel I, Seiler S, de Waha S, Ewen S, Link A, Schuler G, Adams V, Böhm M, Thiele H (2014)
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the intra-aortic balloon pump in cardiogenic shock II (IABP-SHOCK II) trial.
Crit Care 18: 713Mahfoud F, Tunev S, Ruwart J, Schulz-Jander D, Cremers B, Linz D, Zeller T, Bhatt DL, Rocha-Singh K, Böhm M, Melder RJ (2014)
Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
Circ Cardiovasc Interv 7: 813-820Mohr FW, Holzhey D, Möllmann H, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW, GARY Executive Board (2014)
The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease.
Eur J Cardiothorac Surg 46: 808-816Von Scheidt, Zugck C, Pauschinger M, Hambrecht R, Bruder O, Hartmann A, Rauchhaus M, Zahn R, Brachmann J, Tebbe U, Neumann T, Strasser RH, Böhm M, Störk S, Hochadel M, Heidemann P, Senges J (2014)
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.
Clin Res Cardiol 103: 1006-1014Schmieder RE, Schutte R, Schumacher H, Böhm M, Mancia G, Weber MA, McQueen M, Teo K, Yusuf S, ONTARGET/TRANSCEND investigators (2014)
Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies.
Diabetologia 57: 2019-2029Rogacev KS, Zawada AM, Emrich I, Seiler S, Böhm M, Fliser D, Woollard KJ, Heine GH (2014)
Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
Arterioscler Thromb Vasc Biol 34: 2120-2127Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE (2014)
Improvement of albuminuria after renal denervation.
Int J Cardiol 173: 311-315Montero-Perez-Barquero M, Flather M, Roughton M, Coats A, Böhm M, Van Veldhuisen DJ, Babalis D, Solal AC, Manzano L (2014)
Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial.
Eur J Heart Fail 16: 1009-1015Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M (2014)
Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".
Circulation 129: e500-e501Linz D, Ukena C, Esler M, Böhm M, Mahfoud F (2014)
Response to letter regarding article, "renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?".
Circ Res 115: e19-e20Linz D, Mahfoud F, Linz B, Hohl M, Schirmer SH, Wirth KJ, Böhm M (2014)
Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.
Am J Hypertens 27: 1293-1300Komajda M, Böhm M, Borer JS, Ford I, Robertson M, Manolis AJ, Tavazzi L, Swedberg K, SHIFT Investigators (2014)
Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT.
Eur J Heart Fail 16: 810-816Hall RA, Liebe R, Hochrath K, Kazakov A, Alberts R, Laufs U, Böhm M, Fischer HP, Williams RW, Schughart K, Weber SN, Lammert F (2014)
Systems genetics of liver fibrosis: identification of fibrogenic and expression quantitative trait loci in the BXD murine reference population.
PLoS ONE 9: e89279Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP (2014)
Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
Eur Heart J 35: 1752-1759Ekman I, Swedberg K, Böhm M (2014)
Disease-specific health status as a predictor of mortality.
Eur J Heart Fail 16: 923Krum H, Sobotka P, Schlaich M, Böhm M, Esler M (2014)
Authors reply
Lancet 383: 1885-1886Clever YP, Cremers B, Speck U, Dietz U, Böhm M, Scheller B (2014)
Influence of paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: Comparison with drug eluting stent and a bare metal stent.
Cath cardiovasc Interv 84: 323-331
